Delivery Order 75N93018D00011-75N93020F00001
Award Date
5/8/20
Potential Completion Date
4/17/24
Potential Value
$20K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
IDT Biologika GMBH
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price Level of Effort
Place of Performance
Germany
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract is a $70,108.14 delivery order under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle for manufacturing and characterization services for vaccines and other biologics for infectious diseases. The...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to IDT Biologika GMBH, a German biotechnology company. The $1,366,000 contract is for the development, manufacturing, and characterization of various biological materials to support infectious disease research and pandemic preparedness efforts, including influenza virus human challenge material, Staphylococcus aureus...
This is a federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to IDT Biologika GMBH, a foreign-owned, for-profit biotechnology company based in Germany. The contract, valued at a ceiling of $2,723,700.00, is for vaccine manufacturing and characterization services to support infectious disease research and pandemic preparedness efforts. Specific work includes the development,...
This federal contract award, valued at $24,295,876.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract was awarded to IDT Biologika GMBH, a German biotechnology company, to manufacture influenza virus human challenge material for Phase 1 and 2 clinical trials. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of May 14, 2028. No set-aside...
This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $555,600.00 contract was awarded to IDT Biologika GMBH, a German biotechnology company, for the development and manufacture of toxoid fusion proteins and master cell banks. The contract has a total ceiling value of $1,693,261.00 and is a delivery order with a...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The contract, valued at $9,317,000.00, is for the manufacturing of master cell banks for next-generation SARS-CoV-2 vaccines as part of pandemic preparedness efforts. The contract is a delivery order with a firm fixed-price pricing structure and has an ultimate completion...
This is a federal contract award to IDT Biologika GMBH, a German biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $562,089.00, is for the manufacturing of master cell banks for pandemic preparedness related to COVID-19. It is a fixed-price level of effort delivery order contract with a period of performance ending on...
This is a prime contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to IDT Biologika GMBH, a German biotechnology company. The $1,149,011.00 firm fixed price contract is for process development and master bank production of a Staphylococcus aureus protein A product. This work supports NIAID's infectious disease research and pandemic preparedness...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services. The $20,000 firm-fixed-price contract is for the provision of custom oligonucleotide and RNA synthesis services to support NIAID's research and public health initiatives. This is a Blanket Purchase Agreement (BPA) call order under...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $31,202.00 fixed-price level of effort contract is for process development of vaccine candidates, including for SARS-CoV-2. The award has an ultimate completion date of April 15, 2025. ABL has been awarded multiple indefinite...